• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肥胖与重症新型冠状病毒肺炎的风险]

[Obesity and risk of severe COVID-19].

作者信息

Scheen André J

机构信息

Service de diabétologie, nutrition et maladies métaboliques, Département de médecine, CHU Liège, Liège Université, 4000 Liège, Belgique.

出版信息

Rev Med Suisse. 2020 May 27;16(695):1115-1119.

PMID:32462841
Abstract

Obesity represents a higher risk of severe COVID-19 infection, which may lead to the requirement of a mechanical ventilation in intensive care units and premature death. The underlying mechanisms are multiple: alteration of the respiratory performance, presence of comorbidities such as diabetes, hypertension or obstructive sleep apnea, finally inadequate and excessive immunological responses, possibly aggravated by ectopic intrathoracic fat depots. Thus, COVID-19 may challenge the so-called « obesity paradox » commonly reported by intensivists in patients with acute respiratory distress syndrome. These findings require reinforced preventive and curative measures among obese patients to limit the risk of progression towards an unfavorable outcome in case of COVID-19.

摘要

肥胖会增加感染重症 COVID-19 的风险,这可能导致在重症监护病房需要机械通气并引发过早死亡。其潜在机制是多方面的:呼吸功能改变、存在糖尿病、高血压或阻塞性睡眠呼吸暂停等合并症,最后是免疫反应不足和过度,胸腔内异位脂肪堆积可能会加剧这种情况。因此,COVID-19 可能会挑战重症监护医生在急性呼吸窘迫综合征患者中普遍报告的所谓“肥胖悖论”。这些发现要求对肥胖患者加强预防和治疗措施,以限制在感染 COVID-19 时进展为不良结局的风险。

相似文献

1
[Obesity and risk of severe COVID-19].[肥胖与重症新型冠状病毒肺炎的风险]
Rev Med Suisse. 2020 May 27;16(695):1115-1119.
2
[Severe COVID-19, a new complication to be added to numerous comorbidities associated to obesity].[重症新型冠状病毒肺炎,肥胖相关众多合并症中新增的一种并发症]
Rev Med Liege. 2020;75(S1):146-152.
3
Could reperfusion pulmonary oedema explain worsening progress in COVID-19 pneumonia?再灌注性肺水肿能解释新冠病毒肺炎病情的恶化进展吗?
Emerg Med J. 2020 Nov;37(11):705-706. doi: 10.1136/emermed-2020-210085. Epub 2020 Sep 28.
4
ICU outcomes in Covid-19 patients with obesity.肥胖的新冠肺炎患者在重症监护病房的治疗结果
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620971146. doi: 10.1177/1753466620971146.
5
Extracorporeal membrane oxygenation for critically ill patients with coronavirus-associated disease 2019: an updated perspective of the European experience.体外膜肺氧合治疗2019冠状病毒相关疾病危重症患者:欧洲经验的最新观点
Minerva Cardioangiol. 2020 Oct;68(5):368-372. doi: 10.23736/S0026-4725.20.05328-1. Epub 2020 Apr 27.
6
Extracorporeal membrane oxygenation for COVID-19-associated severe acute respiratory distress syndrome and risk of thrombosis.用于治疗新型冠状病毒肺炎相关严重急性呼吸窘迫综合征的体外膜肺氧合及血栓形成风险
Br J Anaesth. 2020 Aug;125(2):e260-e262. doi: 10.1016/j.bja.2020.04.079. Epub 2020 May 4.
7
Obstructive Sleep Apnea, Obesity, and Noninvasive Ventilation: Considerations During the COVID-19 Pandemic.阻塞性睡眠呼吸暂停、肥胖与无创通气:COVID-19大流行期间的考量因素
Anesth Analg. 2020 Aug;131(2):318-322. doi: 10.1213/ANE.0000000000004928.
8
COVID-19 Pandemic Acute Respiratory Distress Syndrome Survivors: Pain After the Storm?新冠疫情急性呼吸窘迫综合征幸存者:风暴过后仍疼痛?
Anesth Analg. 2020 Jul;131(1):117-119. doi: 10.1213/ANE.0000000000004914.
9
Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome.新型冠状病毒肺炎相关急性呼吸窘迫综合征患者的维生素C水平
Crit Care. 2020 Aug 26;24(1):522. doi: 10.1186/s13054-020-03249-y.
10
[Therapy of coronavirus disease 2019 induced acute respiratory distress syndrome is different from traditional acute respiratory distress syndrome].2019冠状病毒病所致急性呼吸窘迫综合征的治疗不同于传统急性呼吸窘迫综合征
Zhonghua Shao Shang Za Zhi. 2020 May 20;36(5):330-333. doi: 10.3760/cma.j.cn501120-20200407-00214.

引用本文的文献

1
Overweight: A risk factor for COVID-19 --- A medical conundrum or a reality?超重:新型冠状病毒肺炎的一个风险因素——医学难题还是现实?
J Family Med Prim Care. 2021 Nov;10(11):4096-4101. doi: 10.4103/jfmpc.jfmpc_889_21. Epub 2021 Nov 29.
2
Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential.二甲双胍降低 COVID-19 严重程度和死亡率:分子机制和治疗潜力。
Biomed Pharmacother. 2021 Dec;144:112230. doi: 10.1016/j.biopha.2021.112230. Epub 2021 Oct 6.
3
Investigational study of the clinical characteristics of confirmed COVID-19 cases.
新型冠状病毒肺炎确诊病例临床特征的调查研究
J Community Hosp Intern Med Perspect. 2021 Jun 21;11(4):450-456. doi: 10.1080/20009666.2021.1926613.
4
Severity of COVID-19 and Treatment Strategy for Patient With Diabetes.2019冠状病毒病的严重程度及糖尿病患者的治疗策略
Front Endocrinol (Lausanne). 2021 Apr 30;12:602735. doi: 10.3389/fendo.2021.602735. eCollection 2021.
5
Leptin correlates with monocytes activation and severe condition in COVID-19 patients.瘦素与 COVID-19 患者的单核细胞激活和严重程度相关。
J Leukoc Biol. 2021 Jul;110(1):9-20. doi: 10.1002/JLB.5HI1020-704R. Epub 2021 Jan 6.
6
The Role of Offspring Genotype-By-Sex Interactions, Independently of Environmental Cues, on the Phenotype Traits of an Obese Swine Model.后代基因型与性别的相互作用(独立于环境线索)对肥胖猪模型表型特征的作用
Biology (Basel). 2020 Dec 4;9(12):445. doi: 10.3390/biology9120445.
7
Identifying novel factors associated with COVID-19 transmission and fatality using the machine learning approach.利用机器学习方法识别与 COVID-19 传播和致死相关的新因素。
Sci Total Environ. 2021 Apr 10;764:142810. doi: 10.1016/j.scitotenv.2020.142810. Epub 2020 Oct 13.